##{"id":84114,"date":"2019-12-12T08:29:37","date_gmt":"2019-12-11T21:29:37","guid":{"rendered":"https:\/\/www.fnarena.com\/?p=84114"},"modified":"2019-12-12T11:24:43","modified_gmt":"2019-12-12T00:24:43","slug":"sponsored-creso-pharma-launch-cannabis-medicinal-cannabis-product-into-africa","status":"publish","type":"post","link":"https:\/\/staging.fnarena.com\/index.php\/2019\/12\/12\/sponsored-creso-pharma-launch-cannabis-medicinal-cannabis-product-into-africa\/","title":{"rendered":"SPONSORED: Creso Pharma launch medicinal cannabis product into Africa"},"content":{"rendered":"<p style=\"text-align:center\"><em>&#8211;The below is a company sponsored announcement&#8211;<\/em><\/p>\n<hr \/>\n<p><strong><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">Creso Pharma Limited ((<\/span><\/span><\/span><a href=\"https:\/\/finfeed.com\/company\/cph\/\"><span style=\"color:#476D9A\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">CPH<\/span><\/span><\/span><\/a><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">&nbsp;)) | (FRA:1X8)<\/span><\/span><\/span> <span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">has begun launch preparations of the cannaQIX&reg; range into Africa.<\/span><\/span><\/span><\/strong><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">Integrating into the African market is part of Creso&rsquo;s <\/span><\/span><\/span><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">drive to deliver its flagship medicinal cannabis product cannaQIX&reg; 50 into new markets.<\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">Working closely with leading South African pharmaceutical company, Pharma Dynamics, a subsidiary of Lupin Limited (NSE: LUPIN), Creso intends to launch cannaQIX&reg; into the region in the March quarter of 2020.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#414042\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">Initial orders worth approximately A$300,000 for the cannaQIX&reg; product range have been made. <\/span><\/span><\/span><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">The cannaQIX&reg; range of products are cannabidiol (CBD) hemp oil-based nutraceuticals using Creso Pharma&rsquo;s proprietary innovative delivery technology.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">They contain broad-spectrum hemp oil extract with CBD aiming to reduce stress and to support mental and nervous functions.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">Pharma Dynamics is an important partner for Creso. <\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">It has the sole distribution rights of Creso&rsquo;s broad-spectrum hemp oil nutraceuticals cannaQIX&reg; product range across South Africa, Namibia, Botswana, Zimbabwe, Swaziland, Lesotho, Angola, Mozambique and Uganda.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#414042\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">Commenting on the collaboration with partner Pharma Dynamics and highlighting their ability to bring an affordable product to market in Africa, Creso Pharma&rsquo;s chief executive and co-founder Miri Halperin Wernli said, &ldquo;We are very excited to work together with our preferred partner Pharma Dynamics for the launch of the cannaQIX&reg; product range into the first key countries in Africa.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#414042\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">&lsquo;&rsquo;We are delighted to offer the customer a top-quality product with a top-quality partner at an affordable price.&rdquo;<\/span><\/span><\/span><\/p>\n<h2>Global expansion?<\/h2>\n<p><span style=\"color:#414042\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">CannaQIX&reg;&rsquo;s global market penetration has increased significantly in 2019.<\/span><\/span><\/span><\/p>\n<p><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">Its reach now extends to Canada, Latin America, Europe, Israel and the APAC region.<\/span><\/span><\/p>\n<p><span style=\"color:#414042\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">In August, Creso announced that it had entered an exclusive distribution agreement with JC Logistics Ltd trading as Medleaf Therapeutics for the exclusive distribution of cannaQIX&reg; in New Zealand.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#414042\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">More recently, Creso announced the arrival of its first shipment of cannaQIX&reg;50 in Australia, to be sold under the brand name &lsquo;LozaCan&rsquo; through its exclusive Australian distributor, Burleigh Heads Cannabis.<\/span><\/span><\/span><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.fnarena.com\/ckfinder\/userfiles\/images\/Picture%201.png\" style=\"height:529px;width:939px\" \/><\/p>\n<p>Burleigh Heads Cannabis has confirmed prescriptions are already taking place, and the product is receiving very positive feedback from physicians and patients.<\/p>\n<p>cannaQIX&reg; 50\/LozaCan has been developed to Good Manufacturing Practice (GMP) standards and is produced in Switzerland by Creso Pharma&rsquo;s partner, Switzerland-based food and pharma development company Domaco, Dr. med Aufdermaur AG to the highest Swiss quality with a &lsquo;Swiss Made&rsquo; label.<\/p>\n<p>Creso Pharma and Burleigh Heads Cannabis are exploring the potential to expand their collaboration to include additional therapeutic\/medicinal cannabis products from Creso Pharma&rsquo;s pipeline.<\/p>\n<p>The delivery follows the recent signing of an Exclusive Distribution Agreement with Burleigh Heads Cannabis in April and the securing of an import permit for Australia.<\/p>\n<p>The collaboration will enable Creso Pharma to leverage Burleigh Heads Cannabis and CDA&rsquo;s local regulatory experience and established distribution networks to facilitate patient access to its products in Australia.<\/p>\n<p>Burleigh Heads Cannabis is a subsidiary of CDA Health Pty Ltd, an established Australian business supporting patient access to medical cannabis products in Australia.<\/p>\n<p>Discussing this milestone event and pointing to its significance in terms of new product launches, Dr Wernli said, &ldquo;We are pleased to announce the first delivery of cannaQIX&reg; 50 in Australia.<\/p>\n<p>&lsquo;&rsquo;Burleigh Heads Cannabis and CDA Clinics Australia continue to rapidly expand their patient reach with their extensive distribution network.<\/p>\n<p>&lsquo;&rsquo;This close partnership enables us to fulfill our mission of bringing life-improving products to patients in Australia.<\/p>\n<h2>2020 outlook<\/h2>\n<p><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">Developments in Australia, along with the new sales being generated in Africa, will assist Creso in delivering strong revenue growth in fiscal 2020.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">Its portfolio of cannabis and hemp-derived products focuses on the four key areas of therapeutics, nutraceuticals, animal health, and cosmetics.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">The company currently has a portfolio of 13 products which have been developed with pharmaceutical expertise and methodological rigour by a qualified pharmaceutical team.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">Four products have been commercialised, and are generating sales, and nine are pending commercialisation.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">Creso anticipates signing with more commercial partners to expand the commercial reach of its two existing human health products cannaQIX<strong>&reg;<\/strong>&nbsp;10 and cannaQIX<strong>&reg;<\/strong>&nbsp;50 and to introduce the newly developed products in additional European countries.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">The company is prioritising Spain, Portugal, the Scandinavian countries, as well as Poland and Israel.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">As for its animal health products, <\/span><\/span><\/span><span style=\"font-family:calibri,sans-serif\"><span style=\"font-size:11.0pt\">partner Virbac is introducing the two initial anibidiol&reg;&nbsp;products into further countries in Europe and will be launching Creso Pharma&#039;s new animal health products in the near future.<\/span><\/span><\/p>\n<hr \/>\n<p><em>Yesterday the corporate announcement above was publicly released. FNArena is acting as a partner in&nbsp;distribution to broaden the reach. No journalists have been involved in the re-publication of this announcement.<\/em><\/p>\n<p><strong>Technical limitations<\/strong><\/p>\n<p><strong><em>If you are reading this story through a third party distribution channel and you cannot see charts included<\/em>, <em>we apologise, but technical limitations are to blame.<\/em><\/strong><\/p>\n<p><em>Find out why FNArena subscribers like the service so much: &quot;<a href=\"http:\/\/www.fnarena.com\/index4.cfm?type=dsp_newsitem&amp;n=29EB960D-9DFF-C00E-7F6B464E5D52E250\">Your Feedback (Thank You)<\/a>&quot; &#8211; Warning this story contains unashamedly positive feedback on the service provided.<\/em><\/p>\n<p><em>FNArena&nbsp;is proud about its track record and past achievements: <a href=\"https:\/\/www.fnarena.com\/index.php\/2018\/10\/03\/rudis-view-ten-years-on-the-world-is-still-turning\/\">Ten Years On<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Creso Pharma  has begun launch preparations of the cannaQIX range into Africa. Integrating into the African market is part of Creso&#8217;s drive to deliver its flagship medicinal cannabis product cannaQIX 50 into new markets.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/84114"}],"collection":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/comments?post=84114"}],"version-history":[{"count":0,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/84114\/revisions"}],"wp:attachment":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media?parent=84114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/categories?post=84114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/tags?post=84114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}